Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
palbociclib cyclin-dependent kinase 4 small molecule Successful target TTD , drugbank , DGIDB Breast[MeSHID:D001940]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Triple Negative Breast Neoplasms[MeSHID:D064726]
Sarcoma[MeSHID:D012509]
Disease Progression[MeSHID:D018450]
Paget's Disease
Mammary[MeSHID:D010144]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Ductal Carcinoma[MeSHID:D044584]
Psychological inhibition[MeSHID:D007266]
Body tissue[MeSHID:D014024]
Carcinoma
Lobular[MeSHID:D018275]
Body part[MeSHID:D018594]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Inflammatory Breast Carcinoma[MeSHID:D058922]
Growth[MeSHID:D006128]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Cessation of life[MeSHID:D003643]
Expiration
function[MeSHID:D045853]
Schizophrenia[MeSHID:D012559]		 0.71 approved,investigational inhibitor
palbociclib cyclin-dependent kinase 6 small molecule Successful target TTD , drugbank , DGIDB Breast[MeSHID:D001940]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Triple Negative Breast Neoplasms[MeSHID:D064726]
Sarcoma[MeSHID:D012509]
Disease Progression[MeSHID:D018450]
Paget's Disease
Mammary[MeSHID:D010144]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Ductal Carcinoma[MeSHID:D044584]
Psychological inhibition[MeSHID:D007266]
Body tissue[MeSHID:D014024]
Carcinoma
Lobular[MeSHID:D018275]
Body part[MeSHID:D018594]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Inflammatory Breast Carcinoma[MeSHID:D058922]
Growth[MeSHID:D006128]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Cessation of life[MeSHID:D003643]
Expiration
function[MeSHID:D045853]
Schizophrenia[MeSHID:D012559]		 0.54 approved,investigational inhibitor
click here to return to the previous page